Literature DB >> 331854

A case of apparent hypopituitarism complicating chronic inflammatory bowel disease in childhood and adolescence.

J R Green, D P O'Donoghue, C R Edwards, A M Dawson.   

Abstract

There is conflicting evidence regarding the adequacy of hypothalamic-pituitary function in children and adolescents with chronic inflammatory bowel disease complicated by growth retardation and delayed sexual maturation. A child with Crohn's disease, who has never received corticosteroid therapy, had delay of both growth and sexual maturation and has been investigated over the course of his disease. In addition to a skull X-ray (normal) and thyroid function tests (normal), a standard insulin tolerance test (insulin 0.15 u/kg) and a standard gonadotropin-releasing hormone (Gn-RH) test (100 microgram Gn-RH i/v) were performed when the bowel disease was in relapse and again during a remission of the bowel disease, achieved by surgery. When the bowel disease was in relapse (coincident with growth arrest) results showed an inadequate release of gonadotrophins and of growth hormone (even after pre-treatment with stilboestrol) but normal release of cortisol and prolactin. During a remission of the bowel disease coinciding with a period of rapid "catch-up" growth, release of growth hormone was normal and that of gonadotrophins supranormal. The demonstration of a reversible apparent partial hypopituitarism in this boy not only re-questions the adequacy of hypothalamic-pituitary function in inflammatory bowel disease but also indicates a potential diagnostic pitfall in the routine investigation of growth retardation if gastrointestinal symptoms are not prominent at presentation.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 331854     DOI: 10.1111/j.1651-2227.1977.tb07962.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN: 0001-656X


  5 in total

1.  Sex differences in statural growth impairment in Crohn's disease: role of IGF-1.

Authors:  Neera Gupta; Robert H Lustig; Michael A Kohn; Marjorie McCracken; Eric Vittinghoff
Journal:  Inflamm Bowel Dis       Date:  2011-02-01       Impact factor: 5.325

2.  Isolated ACTH deficiency associated with Crohn's disease.

Authors:  G Kalambokis; V Vassiliou; T Vergos; L Christou; A Tsatsoulis; E V Tsianos
Journal:  J Endocrinol Invest       Date:  2004-11       Impact factor: 4.256

3.  Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease.

Authors:  S H Murch; V A Lamkin; M O Savage; J A Walker-Smith; T T MacDonald
Journal:  Gut       Date:  1991-08       Impact factor: 23.059

4.  A novel gain-of-function IKBA mutation underlies ectodermal dysplasia with immunodeficiency and polyendocrinopathy.

Authors:  Lena F Schimke; Nikolaus Rieber; Stacey Rylaarsdam; Otávio Cabral-Marques; Nicholas Hubbard; Anne Puel; Laura Kallmann; Stephanie Anover Sombke; Gundula Notheis; Hans-Peter Schwarz; Birgit Kammer; Tomas Hökfelt; Reinald Repp; Capucine Picard; Jean-Laurent Casanova; Bernd H Belohradsky; Michael H Albert; Hans D Ochs; Ellen D Renner; Troy R Torgerson
Journal:  J Clin Immunol       Date:  2013-05-25       Impact factor: 8.317

5.  Nocturnal growth hormone and gonadotrophin secretion in growth retarded children with Crohn's disease.

Authors:  M J Farthing; C A Campbell; J Walker-Smith; C R Edwards; L H Rees; A M Dawson
Journal:  Gut       Date:  1981-11       Impact factor: 23.059

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.